Canopy Growth (CGC) Assets Average (2019 - 2026)
Canopy Growth (CGC) reported Assets Average of $804.5 million for Q1 2026, up 9.24% on a YoY basis from $736.5 million in Q1 2025, and up 2.45% sequentially from $785.3 million in Q4 2025.
Canopy Growth (CGC) Assets Average (2019 - 2026) Analysis & Trends
Canopy Growth (CGC) has 8 years of Assets Average data on file, last reported at $804.5 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 9.24% year-over-year to $804.5 million; the trailing twelve-month figure through Mar 2026 stood at $804.5 million (up 9.24% YoY), and the FY2026 full-year result was $804.5 million, changed 0.28% from the prior year.
- Assets Average grew to $804.5 million in Q1 2026, from $785.3 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $4.7 billion in Q1 2022 to a low of $646.2 million in Q2 2025.
- A 5-year average of $1.6 billion and a median of $981.9 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average slumped 57.9% in 2023 and rose 9.24% in 2026, its largest moves.
- Tracing CGC's Assets Average over 5 years: stood at $2.4 billion in 2022, then plunged by 52.38% to $1.1 billion in 2023, then fell by 22.57% to $868.4 million in 2024, then slipped by 9.57% to $785.3 million in 2025, then advanced by 2.45% to $804.5 million in 2026.
- Business Quant data shows CGC's Assets Average at $804.5 million in Q1 2026, $785.3 million in Q4 2025, and $715.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | 804.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 804.51 Mn |
| Dec 31, 2025 | 785.31 Mn |
| Sep 30, 2025 | 715.15 Mn |
| Jun 30, 2025 | 646.24 Mn |
| Mar 31, 2025 | 736.48 Mn |
| Dec 31, 2024 | 868.39 Mn |
| Sep 30, 2024 | 921.90 Mn |
| Jun 30, 2024 | 952.70 Mn |
| Mar 31, 2024 | 981.89 Mn |
| Dec 31, 2023 | 1.12 Bn |
| Sep 30, 2023 | 1.44 Bn |
| Jun 30, 2023 | 1.72 Bn |
| Mar 31, 2023 | 1.99 Bn |
| Dec 31, 2022 | 2.36 Bn |
| Sep 30, 2022 | 2.65 Bn |
| Jun 30, 2022 | 3.59 Bn |
| Mar 31, 2022 | 4.72 Bn |
| Dec 31, 2021 | 5.08 Bn |
| Sep 30, 2021 | 5.41 Bn |
| Jun 30, 2021 | 5.53 Bn |